Milliner, Dawn <br/><br/>
A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.  [electronic resource] 

 -  Urolithiasis  Aug 2018 
 - 313-323 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>2194-7236 
<br/><br/><label>Standard No.: </label>10.1007/s00240-017-0998-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Biological Therapy--adverse effects<br/>Calcium Oxalate--blood<br/>Child<br/>Child, Preschool<br/>Creatinine--blood<br/>Double-Blind Method<br/>Female<br/>Glomerular Filtration Rate<br/>Humans<br/>Hyperoxaluria, Primary--blood<br/>Kidney Calculi--blood<br/>Kidney Function Tests<br/>Male<br/>Oxalobacter formigenes--metabolism<br/>Placebos--administration & dosage<br/>Renal Elimination<br/>Treatment Outcome<br/>Young Adult